JAYME STORMS: Open Payments
NPI 1083078547 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 51 payments from 11 companies in 2025. Trend: 2023 $996 · 2024 $1,320 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $356 |
| Arcutis Biotherapeutics, Inc. | 14 | $152 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| Incyte Corporation | 4 | $103 |
| Amgen Inc. | 3 | $83 |
| ABBVIE INC. | 4 | $74 |
| Organon LLC | 5 | $66 |
| UCB, Inc. | 2 | $55 |
| Galderma Laboratories, L.P. | 3 | $48 |
| LEO Pharma Inc. | 1 | $29 |
Products named: DUPIXENT, Zoryve, OPZELURA, OTEZLA, VTAMA, Bimzelx, SKYRIZI, LIBTAYO.
Industry payments across CA — which companies pay providers there.
